Pub Date : 2026-01-03DOI: 10.1186/s43088-025-00721-y
Muntaha Mahirah, Nazimah Hamid, Siva Raseetha
Background
This study investigates the physicochemical properties of candlenut (Aleurites moluccana) and daikon radish (Raphanus sativus L.) to explore their potential as natural healing remedies as practised by local communities in Malaysia. Both plants have been used in traditional medicine, but there is limited research on their bioactive compounds and how their characteristics contribute to anti-inflammatory effects.
Results
Colour analysis for fresh candlenut exhibited significantly higher L* value (67.70 ± 0.11) compared to its extract (43.21 ± 0.00). This indicated that fresh candlenut had more whitish hue. Likewise, fresh daikon radish showed more whitish hue compared to its extract. Yellowish hue was more pronounced in fresh candlenut (25.46 ± 2.92) compared to its extract (0.45 ± 0.02). Hydroxyl (O–H), alkenyl (C=C), iso-dimethyl (–CH3), and oxygen-bonded (C–O) functional groups were found in both samples using the FTIR method. Significantly higher tannin content was found in candlenut (91.77 ± 12.18 mg/L), compared to daikon radish (2.13 ± 3.00 mg/L). Similarly, alkaloid concentrations were significantly higher in candlenut (10.30 ± 0.59 mg/L) than in daikon radish (3.56 ± 0.12 mg/L). Phenolic analysis using HPLC identified gallic acid concentrations of 273.43 ± 17.23 mg/L in candlenut and 27.39 ± 20.39 mg/L in daikon radish. Daikon radish detected vanillic acid (28.43 ± 11.92 mg/L) and p-coumaric acid (3.04 ± 0.12 mg/L), which was not detected in candlenut.
Conclusions
These results suggested that candlenut contains higher alkaloids, tannins and gallic acid compared to daikon radish. Vanillic acid and p-coumaric acid, however, were detected in daikon radish only. All three phenolic acids can act as an antioxidant. However, gallic acid was found in higher proportion in candlenut; hence, it has higher potential against oxidative damage condition. This research supports the traditional use of these plants in managing inflammatory conditions and highlights their potential for nutraceutical applications. It may be a useful to eliminate trigger in inflammatory with interaction with receptors. These interactions occur in NF-κB signalling in inflammation pathway usually, and its dysregulation is an important factor for many inflammatory-related diseases such as asthma, atherosclerosis, gout, diabetes, cancer and many more.
{"title":"Characteristics of candlenut (Aleurites moluccana) and daikon radish (Raphanus sativus L.)","authors":"Muntaha Mahirah, Nazimah Hamid, Siva Raseetha","doi":"10.1186/s43088-025-00721-y","DOIUrl":"10.1186/s43088-025-00721-y","url":null,"abstract":"<div><h3>Background</h3><p>This study investigates the physicochemical properties of candlenut (<i>Aleurites moluccana</i>) and daikon radish (<i>Raphanus sativus L.</i>) to explore their potential as natural healing remedies as practised by local communities in Malaysia. Both plants have been used in traditional medicine, but there is limited research on their bioactive compounds and how their characteristics contribute to anti-inflammatory effects.</p><h3>Results</h3><p>Colour analysis for fresh candlenut exhibited significantly higher L* value (67.70 ± 0.11) compared to its extract (43.21 ± 0.00). This indicated that fresh candlenut had more whitish hue. Likewise, fresh daikon radish showed more whitish hue compared to its extract. Yellowish hue was more pronounced in fresh candlenut (25.46 ± 2.92) compared to its extract (0.45 ± 0.02). Hydroxyl (O–H), alkenyl (C=C), iso-dimethyl (–CH<sub>3</sub>), and oxygen-bonded (C–O) functional groups were found in both samples using the FTIR method. Significantly higher tannin content was found in candlenut (91.77 ± 12.18 mg/L), compared to daikon radish (2.13 ± 3.00 mg/L). Similarly, alkaloid concentrations were significantly higher in candlenut (10.30 ± 0.59 mg/L) than in daikon radish (3.56 ± 0.12 mg/L). Phenolic analysis using HPLC identified gallic acid concentrations of 273.43 ± 17.23 mg/L in candlenut and 27.39 ± 20.39 mg/L in daikon radish. Daikon radish detected vanillic acid (28.43 ± 11.92 mg/L) and <i>p</i>-coumaric acid (3.04 ± 0.12 mg/L), which was not detected in candlenut.</p><h3>Conclusions</h3><p>These results suggested that candlenut contains higher alkaloids, tannins and gallic acid compared to daikon radish. Vanillic acid and <i>p</i>-coumaric acid, however, were detected in daikon radish only. All three phenolic acids can act as an antioxidant. However, gallic acid was found in higher proportion in candlenut; hence, it has higher potential against oxidative damage condition. This research supports the traditional use of these plants in managing inflammatory conditions and highlights their potential for nutraceutical applications. It may be a useful to eliminate trigger in inflammatory with interaction with receptors. These interactions occur in NF-κB signalling in inflammation pathway usually, and its dysregulation is an important factor for many inflammatory-related diseases such as asthma, atherosclerosis, gout, diabetes, cancer and many more.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"15 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1186/s43088-025-00721-y.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145887131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.1186/s43088-025-00730-x
Wawid Purwatiningsih, Fedik Abdul Rantam, Aulanni’am Aulanni’am, Heri Prayitno
Background
Organ inflammatory diseases remain a major contributor to global morbidity and mortality, yet current therapies fail to adequately prevent tissue damage progression. Stem cell therapy offers immunomodulatory and regenerative benefits, but its effectiveness varies substantially across administration routes, creating uncertainty in optimal clinical selection.
Main body
This systematic literature review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to compare administration routes of stem cell therapy and its derivatives for organ inflammation. Searches of Scopus, Web of Science, and PubMed databases up to 4 July 2025 identified 790 records; after screening and quality appraisal with Mixed Methods Appraisal Tool (MMAT) 2018, 57 empirical studies published from 2015 onward were included, covering 17 administration routes evaluated against 10 predefined effectiveness and safety domains. Qualitative findings were converted into an ordinal 1–3 scoring system and visualized in a heatmap to enable semiquantitative comparison across routes. Invasive routes such as intramyocardial, intra-arterial, portal vein, intrathecal, and intraparenchymal delivery consistently achieved the highest composite scores for target organ retention, homing, and functional repair, but were penalized for procedure-related risks and feasibility. Noninvasive routes (intravenous, intranasal, nebulized, oral, and sublingual/topical) showed lower target retention but more favorable safety, practicality, and suitability for repeated dosing. Across indications, intraperitoneal delivery tended to outperform intravenous administration for abdominal diseases, whereas intranasal and nebulized approaches were particularly promising for nose-to-brain and lung targeting using relatively low doses.
Conclusion
Stem cell therapy effectiveness is route-specific and reflects trade-offs between target organ delivery and safety–feasibility profiles. The semiquantitative synthesis presented here supports a “route-specific optimization” framework to guide personalized selection of administration routes and to prioritize future translational and clinical research.
背景:器官炎症性疾病仍然是全球发病率和死亡率的主要原因,但目前的治疗方法无法充分预防组织损伤的进展。干细胞治疗提供免疫调节和再生益处,但其有效性在不同的给药途径上差异很大,在最佳临床选择上产生了不确定性。本系统文献综述遵循系统评价和荟萃分析首选报告项目(PRISMA)指南,比较干细胞疗法及其衍生物治疗器官炎症的给药途径。截至2025年7月4日,Scopus、Web of Science和PubMed数据库检索了790条记录;在使用混合方法评估工具(MMAT) 2018进行筛选和质量评估后,纳入了2015年以来发表的57项实证研究,涵盖17种给药途径,根据10个预定义的有效性和安全性领域进行了评估。定性结果被转换成1-3分的顺序评分系统,并在热图中可视化,以便跨路线进行半定量比较。侵入性途径,如心内、动脉、门静脉、鞘内和实质内输送,在靶器官保留、归巢和功能修复方面始终获得最高的综合评分,但在手术相关风险和可行性方面受到惩罚。无创途径(静脉、鼻内、雾化、口服和舌下/局部)显示出较低的靶保留率,但更有利的安全性、实用性和重复给药的适用性。在各种适应症中,腹腔内给药往往优于静脉给药,而鼻内和雾化给药尤其适用于使用相对低剂量的鼻到脑和肺靶向。结论干细胞治疗的有效性是特定途径的,反映了靶器官递送和安全性-可行性之间的权衡。本文提出的半定量综合支持“特定途径优化”框架,以指导个性化的给药途径选择,并优先考虑未来的转化和临床研究。
{"title":"Comparative effectiveness of various administration routes of stem cell therapy and its derivatives for organ inflammation: a systematic review","authors":"Wawid Purwatiningsih, Fedik Abdul Rantam, Aulanni’am Aulanni’am, Heri Prayitno","doi":"10.1186/s43088-025-00730-x","DOIUrl":"10.1186/s43088-025-00730-x","url":null,"abstract":"<div><h3>Background</h3><p>Organ inflammatory diseases remain a major contributor to global morbidity and mortality, yet current therapies fail to adequately prevent tissue damage progression. Stem cell therapy offers immunomodulatory and regenerative benefits, but its effectiveness varies substantially across administration routes, creating uncertainty in optimal clinical selection.</p><h3>Main body</h3><p>This systematic literature review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to compare administration routes of stem cell therapy and its derivatives for organ inflammation. Searches of Scopus, Web of Science, and PubMed databases up to 4 July 2025 identified 790 records; after screening and quality appraisal with Mixed Methods Appraisal Tool (MMAT) 2018, 57 empirical studies published from 2015 onward were included, covering 17 administration routes evaluated against 10 predefined effectiveness and safety domains. Qualitative findings were converted into an ordinal 1–3 scoring system and visualized in a heatmap to enable semiquantitative comparison across routes. Invasive routes such as intramyocardial, intra-arterial, portal vein, intrathecal, and intraparenchymal delivery consistently achieved the highest composite scores for target organ retention, homing, and functional repair, but were penalized for procedure-related risks and feasibility. Noninvasive routes (intravenous, intranasal, nebulized, oral, and sublingual/topical) showed lower target retention but more favorable safety, practicality, and suitability for repeated dosing. Across indications, intraperitoneal delivery tended to outperform intravenous administration for abdominal diseases, whereas intranasal and nebulized approaches were particularly promising for nose-to-brain and lung targeting using relatively low doses.</p><h3>Conclusion</h3><p>Stem cell therapy effectiveness is route-specific and reflects trade-offs between target organ delivery and safety–feasibility profiles. The semiquantitative synthesis presented here supports a “route-specific optimization” framework to guide personalized selection of administration routes and to prioritize future translational and clinical research.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1186/s43088-025-00730-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145886825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-21DOI: 10.1186/s43088-025-00726-7
Sungmin Kim, Mingu Ryu, Hee-Sick Youn, Yun-Gwi Park, Sung-Hwan Moon
Background
Accurate long-term tracking of transplanted stem cells is essential for evaluating therapeutic efficacy, biodistribution, and safety in regenerative medicine. Conventional imaging and molecular tracing methods often lack the sensitivity or temporal stability required for quantifying small residual cell populations over extended periods. Carbon-14 (C-14), a long-lived radioactive isotope, offers a unique opportunity to overcome these limitations by enabling durable and quantitative labeling of stem cells.
Main body
C-14 labeling provides an inheritable molecular marker that is stably incorporated into nucleic acids and other macromolecules, permitting attomole-level detection using accelerator mass spectrometry (AMS). This analytical sensitivity enables reliable quantification of fewer than 100 transplanted cells within complex host tissues—an order of magnitude beyond the detection limits of polymerase chain reaction (PCR) and other conventional assays. Through AMS-based analysis of time-resolved tissue samples, C-14 tracing supports precise assessment of cell survival, migration, engraftment, and long-term persistence. The approach further allows the identification of adverse outcomes such as ectopic engraftment, uncontrolled proliferation, or tumorigenicity by detecting abnormal expansion or mislocalization of labeled cell populations. Collectively, C-14-based tracking provides both quantitative accuracy and temporal resolution suitable for rigorous preclinical evaluation of stem cell therapies.
Conclusion
C-14 tracing represents a powerful analytical platform capable of transforming cell tracking strategies in regenerative medicine. Its unparalleled sensitivity and long-term detection capability offer clear advantages for studying stem cell fate, optimizing therapeutic protocols, and strengthening safety assessments. Continued methodological refinement and broader standardization will be crucial for translating this technology into wider preclinical and clinical use.
{"title":"High-precision in vivo tracking of stem cells using carbon-14 labeling: a novel quantitative approach for assessing therapeutic efficacy and safety","authors":"Sungmin Kim, Mingu Ryu, Hee-Sick Youn, Yun-Gwi Park, Sung-Hwan Moon","doi":"10.1186/s43088-025-00726-7","DOIUrl":"10.1186/s43088-025-00726-7","url":null,"abstract":"<div><h3>Background</h3><p>Accurate long-term tracking of transplanted stem cells is essential for evaluating therapeutic efficacy, biodistribution, and safety in regenerative medicine. Conventional imaging and molecular tracing methods often lack the sensitivity or temporal stability required for quantifying small residual cell populations over extended periods. Carbon-14 (C-14), a long-lived radioactive isotope, offers a unique opportunity to overcome these limitations by enabling durable and quantitative labeling of stem cells.</p><h3>Main body</h3><p>C-14 labeling provides an inheritable molecular marker that is stably incorporated into nucleic acids and other macromolecules, permitting attomole-level detection using accelerator mass spectrometry (AMS). This analytical sensitivity enables reliable quantification of fewer than 100 transplanted cells within complex host tissues—an order of magnitude beyond the detection limits of polymerase chain reaction (PCR) and other conventional assays. Through AMS-based analysis of time-resolved tissue samples, C-14 tracing supports precise assessment of cell survival, migration, engraftment, and long-term persistence. The approach further allows the identification of adverse outcomes such as ectopic engraftment, uncontrolled proliferation, or tumorigenicity by detecting abnormal expansion or mislocalization of labeled cell populations. Collectively, C-14-based tracking provides both quantitative accuracy and temporal resolution suitable for rigorous preclinical evaluation of stem cell therapies.</p><h3>Conclusion</h3><p>C-14 tracing represents a powerful analytical platform capable of transforming cell tracking strategies in regenerative medicine. Its unparalleled sensitivity and long-term detection capability offer clear advantages for studying stem cell fate, optimizing therapeutic protocols, and strengthening safety assessments. Continued methodological refinement and broader standardization will be crucial for translating this technology into wider preclinical and clinical use.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1186/s43088-025-00726-7.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145831412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<div><h3>Background</h3><p>Although several cell- and organoid culture-based systems have been developed to investigate the adverse effects of antineoplastic drugs, they have potential limitations, such as the loss of cellular structure and functions while in vitro culturing or genetic and phenotypic differences from their in vivo counterparts. Overcoming these challenges is crucial for cancer and fertility research. The development of a practicable workflow for generating infertile goat models represents a promising application for the future.</p><h3>Method</h3><p>For this, 12 healthy female goats were divided randomly into two equal groups (test and control). The test group (<i>n</i> = 6) received cyclophosphamide (CTX) intravenously at 30 mg/kg body weight in a single dose, and no treatment was given to the control group (<i>n</i> = 6). Blood samples were taken at different time points, i.e., 0-h, 6-h, 12-h, 18-h, 24-h, 36-h, 48-h, 72-h, 168-h, and 240-h post-CTX injection. The FSH receptor staining was done by the immunohistochemistry technique on formalin-fixed paraffin-embedded (FFPE) tissue sections. The samples chosen for IHC were based on the microscopic lesions observed in histopathology.</p><h3>Results</h3><p>The hemoglobin concentration (%) and total erythrocyte count (million/µl) were markedly reduced from 9.58 ± 0.37 (0 h) to 7.25 ± 0.28 (240 h, <i>p</i> < 0.05) and 24.28 ± 1.05 to 14.34 ± 0.99 (<i>p</i> < 0.001), respectively. However, TLC was the least affected among all the hematological parameters, and in DLC, neutrophil percentage was significantly (<i>p</i> < 0.001) increased at 6 h, and lymphocyte percentage was significantly decreased (<i>p</i> < 0.001). The serum urea and creatinine levels were increased post-CTX treatment, and serum estrogen (pg/ml) and progesterone (ng/ml) concentrations declined from 115.43 ± 19.10 (0 h) to 63.49 ± 8.98 (240 h) and 0.55 ± 0.07 (0 h) to 0.24 ± 0.03 (240 h), respectively. The histological analysis revealed a marked reduction in follicle numbers, suggesting POF post-CTX treatment. Furthermore, the expression analysis of glutathione peroxidase and CuZnSOD was down-regulated. The CuZnSOD expression was down-regulated from 674.64 at 0 h to 0.27 at 18-h post-treatment. However, the expression level of CuZnSOD was significantly (<i>p</i> < 0.001) up-regulated at 36 h of sampling. The expression of glutathione peroxidase was down-regulated from 0 to 24 h (<i>p</i> < 0.05). At the same time, that of Interferon γ and Interleukin 1β were down-regulated initially but up-regulated after 36 h with a 2.90-fold change at 168-h posttreatment for Interferon γ and a 9.96-fold change for Interleukin 1β.</p><h3>Conclusion</h3><p>CTX induces POF by diminishing follicle numbers, hormonal synthesis, and damage at cellular and molecular levels. In conclusion, we were successfully able to establish a safe and efficient infertile goat model, which will be useful to understand the fundamentals and
{"title":"Establishment of safe and efficient infertile goat model using cyclophosphamide and its implications at the cellular and molecular level","authors":"Dayanidhi Jena, Suresh Dinkar Kharche, Shiva Pratap Singh, Gururaj Kumaresan, Sonam Rani, Juhi Pathak, Chetna Gangwar, Rahul Kumar, Mahesh Shivanand Dige, Sabita Behera, Sanjay Kumar Singh","doi":"10.1186/s43088-025-00709-8","DOIUrl":"10.1186/s43088-025-00709-8","url":null,"abstract":"<div><h3>Background</h3><p>Although several cell- and organoid culture-based systems have been developed to investigate the adverse effects of antineoplastic drugs, they have potential limitations, such as the loss of cellular structure and functions while in vitro culturing or genetic and phenotypic differences from their in vivo counterparts. Overcoming these challenges is crucial for cancer and fertility research. The development of a practicable workflow for generating infertile goat models represents a promising application for the future.</p><h3>Method</h3><p>For this, 12 healthy female goats were divided randomly into two equal groups (test and control). The test group (<i>n</i> = 6) received cyclophosphamide (CTX) intravenously at 30 mg/kg body weight in a single dose, and no treatment was given to the control group (<i>n</i> = 6). Blood samples were taken at different time points, i.e., 0-h, 6-h, 12-h, 18-h, 24-h, 36-h, 48-h, 72-h, 168-h, and 240-h post-CTX injection. The FSH receptor staining was done by the immunohistochemistry technique on formalin-fixed paraffin-embedded (FFPE) tissue sections. The samples chosen for IHC were based on the microscopic lesions observed in histopathology.</p><h3>Results</h3><p>The hemoglobin concentration (%) and total erythrocyte count (million/µl) were markedly reduced from 9.58 ± 0.37 (0 h) to 7.25 ± 0.28 (240 h, <i>p</i> < 0.05) and 24.28 ± 1.05 to 14.34 ± 0.99 (<i>p</i> < 0.001), respectively. However, TLC was the least affected among all the hematological parameters, and in DLC, neutrophil percentage was significantly (<i>p</i> < 0.001) increased at 6 h, and lymphocyte percentage was significantly decreased (<i>p</i> < 0.001). The serum urea and creatinine levels were increased post-CTX treatment, and serum estrogen (pg/ml) and progesterone (ng/ml) concentrations declined from 115.43 ± 19.10 (0 h) to 63.49 ± 8.98 (240 h) and 0.55 ± 0.07 (0 h) to 0.24 ± 0.03 (240 h), respectively. The histological analysis revealed a marked reduction in follicle numbers, suggesting POF post-CTX treatment. Furthermore, the expression analysis of glutathione peroxidase and CuZnSOD was down-regulated. The CuZnSOD expression was down-regulated from 674.64 at 0 h to 0.27 at 18-h post-treatment. However, the expression level of CuZnSOD was significantly (<i>p</i> < 0.001) up-regulated at 36 h of sampling. The expression of glutathione peroxidase was down-regulated from 0 to 24 h (<i>p</i> < 0.05). At the same time, that of Interferon γ and Interleukin 1β were down-regulated initially but up-regulated after 36 h with a 2.90-fold change at 168-h posttreatment for Interferon γ and a 9.96-fold change for Interleukin 1β.</p><h3>Conclusion</h3><p>CTX induces POF by diminishing follicle numbers, hormonal synthesis, and damage at cellular and molecular levels. In conclusion, we were successfully able to establish a safe and efficient infertile goat model, which will be useful to understand the fundamentals and ","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1186/s43088-025-00709-8.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145612927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Opuntia cactus, or prickly pear, is a good source of bioactive compounds, especially betalains that have high antioxidant activity and play an important role in human health. However, despite their nutritional and functional benefits, these compounds are highly sensitive to environmental conditions, leading to reduced stability and bioactivity during processing and digestion.
Scope
To overcome the stability challenges, double emulsions (W1/O/W2) have emerged as an innovative encapsulation and delivery system for bioactive compounds. This review explores the structural characteristics of double emulsions, their encapsulation mechanisms, and models describing release kinetics under digestive conditions. Factors influencing emulsion stability—including emulsifier type, droplet size, phase ratio, and processing conditions—are critically discussed. Studies demonstrate that double emulsions can significantly enhance the stability, bioaccessibility, and controlled release of sensitive compounds such as betalains, while maintaining desirable sensory and functional properties. Their successful incorporation into various food matrices, including beverages, dairy, and bakery products, has resulted in improved nutritional profiles, antioxidant retention, and extended shelf life. Additionally, industrial scalability and formulation challenges are examined, emphasizing the importance of optimizing processing parameters and ensuring consumer acceptability.
Conclusion
Double emulsions provide a novel approach to improve the stability and delivery of bioactive ingredients in functional foods. Future research and development should focus on optimizing their design and functionality, enabling widespread application across the food industry and healthier food products.